De novo substitutions of TRPM3 cause intellectual disability and epilepsy

Publication date

2019-10-01

Authors

Dyment, David A.
Terhal, Paulien A.ISNI 0000000394056998
Rustad, Cecilie F.
Tveten, Kristian
Griffith, Christopher
Jayakar, Parul
Shinawi, Marwan
Ellingwood, Sara
Smith, Rosemarie
van Gassen, Koen L.I.ISNI 000000039116474X

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

Abstract

The developmental and epileptic encephalopathies (DEE) are a heterogeneous group of chronic encephalopathies frequently associated with rare de novo nonsynonymous coding variants in neuronally expressed genes. Here, we describe eight probands with a DEE phenotype comprising intellectual disability, epilepsy, and hypotonia. Exome trio analysis showed de novo variants in TRPM3, encoding a brain-expressed transient receptor potential channel, in each. Seven probands were identically heterozygous for a recurrent substitution, p.(Val837Met), in TRPM3’s S4–S5 linker region, a conserved domain proposed to undergo conformational change during gated channel opening. The eighth individual was heterozygous for a proline substitution, p.(Pro937Gln), at the boundary between TRPM3’s flexible pore-forming loop and an adjacent alpha-helix. General-population truncating variants and microdeletions occur throughout TRPM3, suggesting a pathomechanism other than simple haploinsufficiency. We conclude that de novo variants in TRPM3 are a cause of intellectual disability and epilepsy.

Keywords

Genetics, Genetics(clinical)

Citation

Dyment, D A, Terhal, P A, Rustad, C F, Tveten, K, Griffith, C, Jayakar, P, Shinawi, M, Ellingwood, S, Smith, R, van Gassen, K, McWalter, K, Innes, A M & Lines, M A 2019, 'De novo substitutions of TRPM3 cause intellectual disability and epilepsy', European Journal of Human Genetics, vol. 27, no. 10, pp. 1611-1618. https://doi.org/10.1038/s41431-019-0462-x